Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about BMY

Recent news which mentions BMY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Is Bristol Myers Squibb Stock a Buy?
Tickers BMY
Tags Recent Press Releases Market News BMY
From Motley Fool
Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
Tickers BMY ENB KHC
Tags Market News Recent Press Releases KHC
From Motley Fool
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Tickers BMY NEWS
Tags General Briefs Expert Ideas
From Benzinga
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue
Tickers BMY NEWS
Tags Legal General Benzinga
From Benzinga
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
Tickers AMGN BLK BMY CSCO
Tags Market News CSCO VZ
From Motley Fool
2 Beaten-Down Dividend Stocks to Buy and Hold
Tickers BMY CVS
Tags CVS BMY Recent Press Releases
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Tickers ALT AMGN BMY BSX
Tags BZI/AUOA INCY AMGN
From Benzinga
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
Tickers BMY NEWS SYRS
Tags Market News Pharmaceutical why it's moving
From Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
Tickers ABBV BMY NBIX NEWS
Tags Biotech Stories That Matter Benzinga
From Benzinga
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Tickers ARGX BMY IFF IHRT
Tags Markets Market News Analyst Ratings
From Benzinga
Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock
Tickers ABBV BMY LLY NEWS
Tags General Stories That Matter Upgrades
From Benzinga
What's Going On With Bristol-Myers Squibb Shares Monday?
Tickers ABBV BMY NEWS
Tags News why it's moving BMY
From Benzinga
AbbVie's Emraclidine For Schizophrenia 'Surprisingly Disappoints,' Analyst Says Pipeline Is Underappreciated
Tickers ABBV BMY NEWS
Tags Analyst Color Market News Analyst Ratings
From Benzinga
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Tickers BMY EVO NEWS NVO
Tags EVO Rumors Media
From Benzinga
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
Tickers ABBV BMY NEWS
Tags Benzinga Stories That Matter Biotech
From Benzinga
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
Tickers AFRM BMY BTBT BTDR
Tags BTDR NNOX BMY
From Benzinga
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Tickers ABBV ALNY BMY GILD
Tags General Expert Ideas Briefs
From Benzinga
Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
Tickers BMY NEWS NVO TEVA
Tags Briefs Biotech Benzinga
From Benzinga
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Tickers BMY MRK NEWS SMMT
Tags why it's moving Analyst Ratings Initiation
From Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Tickers BMY
Tags BZI/SHORTHIST Market News Short Sellers
From Benzinga
Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious
Tickers BMY NEWS
Tags Large Cap News Health Care
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags AAPL $BTC INTC
From Benzinga
Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript
Tickers BMY
Tags BMY Market News Recent Press Releases
From Motley Fool
Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit
Tickers BMY NEWS
Tags News Large Cap Guidance
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Biotech Benzinga Briefs
From Benzinga
Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy
Tickers BMY GILD LYEL NEWS
Tags General LYEL Briefs
From Benzinga
Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb
Tickers BMY
Tags BMY Markets Market News
From Benzinga
800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio
Tickers BMY IBRX MRK NEWS
Tags IBRX Analyst Color Market News
From Benzinga
Why Is Evotec Stock Gaining Today?
Tickers BMY EVO NEWS
Tags Benzinga Stories That Matter Biotech
From Benzinga
Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
Tickers ALMS BMY NEWS TAK
Tags General Biotech Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.